Interview | Mikihiro FujiyanbspJournal of Gastrointesti
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1384

Journal of Gastrointestinal & Digestive System received 1384 citations as per Google Scholar report

Journal of Gastrointestinal & Digestive System peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page
Mikihiro Fujiya
Mikihiro Fujiya

Mikihiro Fujiya
Division of Gastroenterology and Hematology/Oncology
Department of Medicine
Asahikawa Medical University
Tel. 0166-68-2462
Fax 0166-68-2469
Read Interview session with Mikihiro Fujiya


Mikihiro Fujiya is from Asahikawa Medical University (Academia) Department of Medicine, Division of Gastroenterology and Hematology/Oncology Midorigaoka-higashi Asahikawa, Japan

Research Interest

Mikihiro Fujiya research interests include Adenocarcinoma, Adenoma, Adenomatous Polyposis Coli.


1. How many years have you been associated with the current research?
15 years

2. What is the research topic you are working on now?
 Host-microbial interaction
 microRNA and RNA-associated molecules
 Endoscopy

3. What are attributes for a quality article?
 I identified effective molecules produced by bacteria (probiotics). The molecules are expected to be used as a new drug for intestinal disorders (Fujiya, Cell H&M, 2007; Segawa, Fujiya, PlosOns, 2011).
 I identified that miR-18a directly bound to oncogenic protein hnRNP A1 and degraded the protein through autophagolysosomal pathway, leading apoptosis of cancer cells (Fujiya, Oncogene, in press).
 Image-enhanced endoscopies are useful for diagnosing intestinal disorders including colon cancer, lymphoma and inflammatory bowel diseases (Sato, Fujiya, Endoscopy, 2011; Kashima, Nata, Fujiya, GUT, 2011; Fujiya, Gastrointestinal Endoscopy, 2013; Fujiya, Gastrointestinal Endoscopy, 2014, e.g.).

4. Do you have any research funding (NIH or other national funding) now?
Some national funds are supporting my researches.

5. When did you become an editor of OMICS Journal?
Around 3 years ago

6. Where can the journal find the maximum scope in terms of niche?
Novel insights concerning both clinical and basic science

7. What is your greatest career accomplishment?
Associate professor

8. How does the published scientific content assist the potential researchers?
Cost down

9. What is the purpose of serving as an editor?
To promote the journal and learn research topics from submitted journal.

10. Do you have any patents?

11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?

12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?

13. How would you define your experience with OMICS Group?
Clinical and basic research of the intestinal tract

14. Your opinion on conducting Editorial Board meetings at related Conferences?
I don’t think the meetings are useful to promote the journal.

15. Would you recommend OMICS to your friends or colleagues?
Yes. 16. How do you differentiate Journal of Gastrointestinal & Digestive System with other journals in the field?
It would be better to ask young investigators to submit articles with very low fee.